• Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
  
• SARS-CoV2: Use of inhibitors of the renin-angiotensin system in patients with COVID-19
  
• Access the full podcast library on all CV topics

• What COVID-19 is taking away from us – Milan, Italy
• WATCH - Cardiac involvement in COVID-19 - Staffordshire, UK
• COVID-19: the aftermath - Piacenza, Italy 
• Psychological support for staff – London, UK
• m-Health: Apps to the rescue – Maastricht, Netherlands  
• Connecting COVID-19 patients with their families – Madrid, Spain 
• Young cardiologist in the eye of the storm – Madrid, Spain
  
• COVID-19 patients: scared and alone - Pavia, Italy
• Protecting cardiologists during the COVID-19 epidemic – Wuhan, China 
• And the wave became a tsunami – Paris, France 
• Diagnosing the first COVID-19 patient in Italy – Codogno, Italy 
  
• Exhausted and trying to cope – Lombardy, Italy
• COVID-19: digital health swings into action

From the European Heart Journal

• Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid COVID-19  New
• Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 
• EAPCI Position Statement on invasive management of ACS during the COVID-19 pandemic
• Characteristics and clinical significance of cardiac injury in patients with severe COVID-19
• Circulating plasma concentrations of ACE 2 in patients with HF and effects of RAA inhibitors
• Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Italy
• A tale of two countries. How to build resilient healthcare systems   
  
• Deleterious effects of viral pneumonia on cardiovascular system
• From ‘Do No Harm’ to ‘Do Maximal Good’: an evolving concept   
  
• SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? 
• Coronaviruses and the cardiovascular system: acute and long-term implications 
  
  

From the European Heart Journal - Clinical Cases

• Angioedema in COVID-19 
• Percutaneous thrombectomy in a patient supported by extracorporeal membrane oxygenation 
• SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted Tako-Tsubo syndrome
• Multivessel spontaneous coronary artery dissection presenting in a patient with acute SARS-CoV-2
• ST-elevation myocardial infarction and pulmonary embolism in acute respiratory distress syndrome  
• Multivessel coronary thrombosis in a patient with COVID-19 pneumonia  
• Large saddle pulmonary embolism in a woman infected with COVID-19 pneumonia  
• Typical Tako-Tsubo syndrome triggered by SARS-CoV-2 infection
• Transient complete heart block in a patient with critical COVID- 19
• COVID-19 related myocarditis in a 21-year old female patient
• Acute myocarditis as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection 
• Acute pulmonary embolism and COVID-19 pneumonia: a random association? 
• Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 
   

From European Heart Journal - Case Reports

• Subacute perimyocarditis in a young patient with COVID-19 infection 
• Atherosclerotic spontaneous coronary artery dissection (A-SCAD) in a patient with COVID-19 
• Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series
  
  

From Cardiovascular Research 

• COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis and treatment  
• Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications  
• Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections  
• The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and CVD  
• The ACE2 expression indicates new potential mechanism of heart injury in patients with SARS-CoV-2  
  
  

From EHJ - Acute Cardiovascular Care

• Implications for prehospital, emergency and hospital care in patients with ACS  
• Respiratory management in severe acute respiratory syndrome coronavirus 2 infection  
• Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol  
• Medical treatment options for COVID-19
• The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions
• Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds 
• Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic 
  
  

From EHJ - Cardiovascular Imaging

• Unusual presentation of acute coronary syndrome in a patient with SARS-CoV-2 infection 
• A case of Tako-Tsubo cardiomyopathy with COVID 19
• The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients 
• Myocarditis revealing COVID-19 infection in a young patient  
• Acute pulmonary embolism with intramural RV thrombus in SARS-CoV-2-positive patient 
• EACVI recommendations on precautions, indications, prioritization, and protection
  
  

From European Journal of Cardiovascular Nursing

• Delivering healthcare remotely to cardiovascular patients during COVID-19: A review of evidence
  
  

From European Journal of Preventive Cardiology  

• Effect of coronavirus infection on the human heart: A scoping review    
• Cardiac patient care during a pandemic: how to reorganise a HF unit at the time of COVID-19    
• Cardiovascular disease and COVID-19: les liaisons dangereuses
• Amiodarone as a possible therapy for coronavirus infection 
  
  

From European Journal of Heart Failure 

• COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation 
• The consequences of the pandemic for self‐care in-patients with a Left Ventricular Assist Device 
• Caring for people with heart failure beyond the pandemic; the advantages of home telemonitoring
• Myocardial localization of coronavirus in COVID‐19 cardiogenic shock
  
  

From other ESC sources

• Webinars - Position statements - Commentaries

Overview of management of coronavirus

• Experts question guidance to reuse PPE 
• Handbook of COVID-19: Prevention and treatment

Medication

• Reminder of risk of serious side effects with chloroquine and hydroxychloroquine 
• ESC resources on chloroquine and cardiovascular side effects
• Thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up

COVID-19 and CVD

• Practical recommendations for the management of diabetes in patients with COVID-19
• Renin–Angiotensin–Aldosterone system blockers and the risk of COVID-19
• Renin–Angiotensin–Aldosterone system inhibitors and risk of COVID-19
• Cardiovascular disease, drug therapy, and mortality in COVID-19
• Pulmonary and cardiac pathology in Covid-19: First autopsy series from New Orleans
• COVID-19: Providing ongoing care to patients with cardiovascular disease in a pandemic
• COVID-19 and the cardiovascular system
• Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

 General resources 

• Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility 
• Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in China 
• New NIH resource to analyze COVID-19 literature: The COVID-19 Portfolio Tool  
• OUP resources on COVID-19
• WHO information on COVID-19

• A Vital Message to Patients from ESC President Barbara Casadei 
  
  
• COVID-19 and Heart Patients (Q&A)  Also available in Russian, German and Romanian

The ESC Patient Forum has received many questions about COVID-19. This page provides helpful answers, including a pdf format, to share with your own patients.